Federal
A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2019 as "PCOS Awareness Month".
Source: Congress.gov ·
1,036 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
III
116TH CONGRESS
1ST SESSION
S. RES. 317
Recognizing the seriousness of polycystic ovary syndrome (PCOS) and ex-
pressing support for the designation of September 2019 as ‘‘PCOS
Awareness Month’’.
IN THE SENATE OF THE UNITED STATES
SEPTEMBER 18, 2019
Ms. WARREN (for herself, Mr. PERDUE, Mr. CARDIN, Ms. BALDWIN, Mr.
BLUMENTHAL, Mrs. FISCHER, Mr. ISAKSON, Ms. STABENOW, Mr. BOOK-
ER, Mrs. FEINSTEIN, Mr. VAN HOLLEN, Mr. PETERS, and Ms. ROSEN)
submitted the following resolution; which was referred to the Committee
on Health, Education, Labor, and Pensions
RESOLUTION
Recognizing the seriousness of polycystic ovary syndrome
(PCOS) and expressing support for the designation of
September 2019 as ‘‘PCOS Awareness Month’’.
Whereas polycystic ovary syndrome (in this preamble referred
to as ‘‘PCOS’’) is a common health problem among
women and girls involving a hormonal imbalance;
Whereas there is no universal definition of PCOS, but re-
searchers
estimate
that
between
5,000,000
and
10,000,000 women in the United States are affected by
the condition;
Whereas, according to a 2004 study, the annual burden of
PCOS
in
the
United
States
is
an
estimated
VerDate Sep 11 2014
02:18 Sep 19, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\SR317.IS
SR317
kjohnson on DSK79L0C42 with BILLS
2
•SRES 317 IS
$4,360,000,000, and this figure pertains to only the re-
productive years of women and does not consider the cost
of other comorbidities, including obstetrical complica-
tions, or the cost of metabolic morbidities in post-meno-
pause or adolescence;
Whereas PCOS can affect girls at the onset of puberty and
throughout the remainder of their lives;
Whereas the symptoms of PCOS include infertility, irregular
or absent menstrual periods, acne, weight gain, thinning
of scalp hair, excessive facial and body hair growth, nu-
merous small ovarian cysts, pelvic pain, and mental
health problems;
Whereas women with PCOS have higher rates of psychosocial
disorders, including depression, anxiety, bipolar disorder,
and eating disorders, and are at greater risk for suicide;
Whereas adolescents with PCOS often are not diagnosed, and
many have metabolic dysfunction and insulin resistance,
which can lead to type 2 diabetes, cardiovascular disease,
obstructive sleep apnea, nonalcoholic fatty liver disease,
and endometrial cancer at a young adult age;
Whereas PCOS is the most common cause of female infer-
tility;
Whereas PCOS in pregnancy is associated with increased risk
of gestational diabetes, preeclampsia, pregnancy-induced
hypertension, preterm delivery, cesarean delivery, mis-
carriage, and fetal and infant death;
Whereas women with PCOS are at increased risk of devel-
oping high blood pressure, high cholesterol, stroke, and
heart disease (the leading cause of death among women);
VerDate Sep 11 2014
02:18 Sep 19, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\SR317.IS
SR317
kjohnson on DSK79L0C42 with BILLS
3
•SRES 317 IS
Whereas women with PCOS have a more than 50 percent
chance of developing type 2 diabetes or prediabetes be-
fore the age of 40;
Whereas women with PCOS may be at a higher risk for
breast cancer and ovarian cancer, and their risk for de-
veloping endometrial cancer is 3 times higher than
women who do not have PCOS;
Whereas research has found genetic evidence of a causal link
between depression and PCOS;
Whereas research has indicated PCOS shares a genetic archi-
tecture with metabolic traits, as evidenced by genetic cor-
relations between PCOS and obesity, fasting insulin, type
2 diabetes, lipid levels, and coronary artery disease;
Whereas adolescents with PCOS are at markedly increased
risk for type 2 diabetes, fatty liver disease, and heart dis-
ease;
Whereas PCOS negatively alters metabolic function inde-
pendent of, but exacerbated by, an increased body mass
index (BMI);
Whereas an estimated 50 percent of women with PCOS are
undiagnosed, and many remain undiagnosed until they
experience fertility difficulties or develop type 2 diabetes
or other cardiometabolic disorders;
Whereas the cause of PCOS is unknown, but researchers
have found strong links to a genetic predisposition and
significant insulin resistance, which affects up to 70 per-
cent of women with PCOS; and
Whereas there is no known cure for PCOS: Now, therefore,
be it
Resolved, That the Senate—
1
VerDate Sep 11 2014
02:18 Sep 19, 2019
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\SR317.IS
SR317
kjohnson on DSK79L0C42 with BILLS
4
•SRES 317 IS
(1) recognizes polycystic ovary syndrome (in
1
this resolution referred to as ‘‘PCOS’’) as a serious
2
disorder that impacts many aspects of health, in-
3
cluding cardiometabolic, reproductive, and mental
4
health, and quality of life;
5
(2) expresses support for the designation of
6
September 2019 as ‘‘PCOS Awareness Month’’;
7
(3) supports the goals and ideals of PCOS
8
Awareness Month, which are—
9
(A) to increase awareness of, and edu-
10
cation about, PCOS and its connection to
11
comorbidities,
such
as
type
2
diabetes,
12
endometrial cancer, cardiovascular disease, non-
13
alcoholic fatty liver disease, and mental health
14
disorders, among the general public, women,
15
girls, and health care professionals;
16
(B) to improve diagnosis and treatment of
17
PCOS;
18
(C) to disseminate information on diag-
19
nosis, treatment, and management of PCOS,
20
including prevention of comorbidities such as
21
type 2 diabetes, endometrial cancer, cardio-
22
vascular disease, nonalcoholic fatty liver dis-
23
ease, and eating disorders; and
24
VerDate Sep 11 2014
02:18 Sep 19, 2019
Jkt 089200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\SR317.IS
SR317
kjohnson on DSK79L0C42 with BILLS
5
•SRES 317 IS
(D) to improve quality of life and outcomes
1
for women and girls with PCOS;
2
(4) recognizes the need for further research,
3
improved treatment and care options, and a cure for
4
PCOS;
5
(5) acknowledges the struggles affecting all
6
women and girls afflicted with PCOS in the United
7
States;
8
(6) urges medical researchers and health care
9
professionals to advance their understanding of
10
PCOS to improve research, diagnosis, and treatment
11
of PCOS for women and girls; and
12
(7) encourages States, territories, and localities
13
to support the goals and ideals of PCOS Awareness
14
Month.
15
Æ
VerDate Sep 11 2014
02:18 Sep 19, 2019
Jkt 089200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\SR317.IS
SR317
kjohnson on DSK79L0C42 with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.